Skip to main content
logo
Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.40
+0.05 (0.11%)
Mar 24, 2026, 1:30 PM CST

TPE:6657 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.677.757.167.357.49
Revenue Growth (YoY)
-0.97%8.26%-2.63%-1.84%5.76%
Cost of Revenue
1.842.061.932.192.13
Gross Profit
5.835.695.235.175.36
Selling, General & Admin
86.6881.0181.9463.1465.69
Research & Development
194.43179.85185.13213.6861.76
Operating Expenses
281.11260.86267.06276.82127.45
Operating Income
-275.28-255.17-261.84-271.65-122.09
Interest Expense
-0.46-0.21-0.21-0.21-0.28
Interest & Investment Income
14.8712.5110.443.932.41
Currency Exchange Gain (Loss)
-11.3-8.782.260.01
Other Non Operating Income (Expenses)
2.470.10.230.01-0.28
EBT Excluding Unusual Items
-258.4-231.47-260.16-265.66-120.24
Gain (Loss) on Sale of Investments
-0.37---
Gain (Loss) on Sale of Assets
---0.22--
Other Unusual Items
-0.02---
Pretax Income
-258.4-231.08-260.38-265.66-120.24
Net Income
-258.4-231.08-260.38-265.66-120.24
Net Income to Common
-258.4-231.08-260.38-265.66-120.24
Shares Outstanding (Basic)
8876726760
Shares Outstanding (Diluted)
8876726760
Shares Change (YoY)
15.96%5.97%8.08%10.96%1.67%
EPS (Basic)
-2.92-3.03-3.62-3.99-2.00
EPS (Diluted)
-2.92-3.03-3.62-3.99-2.00
Free Cash Flow
-224.72-181.47-225.89-239.29-106.18
Free Cash Flow Per Share
-2.54-2.38-3.14-3.59-1.77
Gross Margin
76.00%73.43%73.02%70.26%71.56%
Operating Margin
-3587.11%-3292.93%-3657.96%-3695.47%-1630.26%
Profit Margin
-3367.24%-2982.06%-3637.64%-3613.98%-1605.50%
Free Cash Flow Margin
-2928.30%-2341.79%-3155.81%-3255.16%-1417.84%
EBITDA
-252.7-238.69-244.58-253.78-105.63
D&A For EBITDA
22.5716.4817.2617.8816.46
EBIT
-275.28-255.17-261.84-271.65-122.09
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.